<i>miR-146a</i> – <i>Traf6</i> regulatory axis controls autoimmunity and myelopoiesis, but is dispensable for hematopoietic stem cell homeostasis and tumor suppression

Nathaniel Magilnick, Estefany Y. Reyes, Wei-Le Wang, Steven Vonderfecht, Jin Gohda, Jun‐ichiro Inoue, Mark Boldin

Proceedings of the National Academy of Sciences · 2017 · 59 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

Significance Aberrant inflammation is the root cause of numerous human diseases, from autoimmunity to cancer. microRNA-146a ( miR-146a ), a member of a large class of small regulatory RNAs, functions as a critical molecular brake on inflammation and malignant transformation. However, the molecular mechanism through which miR-146a exerts its regulatory activity in immune cells is unclear. Using mouse genetics, we have examined the role of the miR-146a–Traf6 signaling axis and found that although this miRNA–target interaction is responsible for regulating normal myeloid cell development and autoimmunity, it is dispensable for hematopoietic stem cell homeostasis and tumor suppression.

References

38